The Federal Drug Administration has begun officially required that the initial dosage level of popular sleep-aid Lunesta be reduced.
The change came after a study which concluded that even though adults taking the drug woke up and felt alert, they were actually not suitable to drive, according to WaPo.
Eszopiclone, the main ingredient in Lunesta, has a regular starting dosage of 2 mg. The FDA mandated that the dosage be halved to one to combat the problem.
The FDA added that people on 2 mg or more should consult their doctor on how to make sure they aren’t driving unwittingly fatigued from the medication.
“To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia,” said Ellis Unger, of FDA’s Center for Drug Evaluation and Research.
In 2013 alone, three million prescriptions for Lunesta were written. The changes will apply to the generic version as well.
If patients have questions about other sleep-aids, they are advised to speak with their doctor.
By: Cassie Fambro